Rosa Helena Bustos-Cruz (Rosa-Helena Bustos, Rosa Helena Bustos)

Scopus Author ID Scopus Author ID Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 30

Top Topics

Methicillin Resistant Staphylococcus Aureus

Systematic Review

Acinetobacter Baumannii

Mesenchymal Stem Cells

Top Venues

Antibiotics (Basel, Switzerland)

Journal of clinical psychopharmacology

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Loren Zambrano, Rosa Helena Bustos-Cruz, Edgar Beltran, Daniel Gomez, Sara Arias, Wilson Briceño
STOPP-START Criteria Used to Identify the Elderly Population Prone to Potentially Inadequate Prescribing in a Colombian Cohort. Current aging science 17 (2) (2024)
Santiago Pedraza-Sanabria, Seetal Dodd, Luis Fernando Giraldo-Cadavid, Karen Whittingham, Rosa Helena Bustos-Cruz
Existing and Emerging Technologies for Therapeutic Monitoring of Lithium: A Scoping Review. Journal of clinical psychopharmacology 44 (3) (2024)
Juan-David Huertas, Yuli-Viviana Fuentes, Julio-Cesar Garcia, Rosa Helena Bustos-Cruz
The Role of Education in Nanomedicine as a Current Need for Academic Programs Related to the Healthcare Field: A Scoping Review. Advances in medical education and practice 15 (2024)
Juan-David Huertas, Yuli-Viviana Fuentes, Julio-Cesar Garcia, Rosa Helena Bustos-Cruz
The Role of Education in Nanomedicine as a Current Need for Academic Programs Related to the Healthcare Field: A Scoping Review. Advances in medical education and practice 15 (2024)
Santiago Pedraza-Sanabria, Seetal Dodd, Luis Fernando Giraldo-Cadavid, Karen Whittingham, Rosa Helena Bustos-Cruz
Existing and Emerging Technologies for Therapeutic Monitoring of Lithium: A Scoping Review. Journal of clinical psychopharmacology 44 (3) (2024)
Santiago Pedraza-Sanabria, Seetal Dodd, Luis Fernando Giraldo-Cadavid, Karen Whittingham, Rosa Helena Bustos-Cruz
Existing and Emerging Technologies for Therapeutic Monitoring of Lithium: A Scoping Review. Journal of clinical psychopharmacology (2024)
Vivian Garzon, J-Pablo Salvador, María-Pilar Marco, Daniel G-Pinacho, Rosa Helena Bustos-Cruz
Development and ELISA Characterization of Antibodies against the Colistin, Vancomycin, Daptomycin, and Meropenem: A Therapeutic Drug Monitoring Approach. Antibiotics (Basel, Switzerland) 13 (7) (2024)
Santiago Pedraza-Sanabria, Seetal Dodd, Luis Fernando Giraldo-Cadavid, Karen Whittingham, Rosa Helena Bustos-Cruz
Existing and Emerging Technologies for Therapeutic Monitoring of Lithium: A Scoping Review. Journal of clinical psychopharmacology 44 (3) (2024)
Vivian Garzon, J-Pablo Salvador, María-Pilar Marco, Daniel G-Pinacho, Rosa Helena Bustos-Cruz
Development and ELISA Characterization of Antibodies against the Colistin, Vancomycin, Daptomycin, and Meropenem: A Therapeutic Drug Monitoring Approach. Antibiotics (Basel, Switzerland) 13 (7) (2024)
Loren Zambrano, Rosa Helena Bustos-Cruz, Edgar Beltran, Daniel Gomez, Sara Arias, Wilson Briceño
STOPP-START Criteria Used to Identify the Elderly Population Prone to Potentially Inadequate Prescribing in a Colombian Cohort. Current aging science (2024)
Vivian Garzon, J-Pablo Salvador, María-Pilar Marco, Daniel G-Pinacho, Rosa Helena Bustos-Cruz
Development and ELISA Characterization of Antibodies against the Colistin, Vancomycin, Daptomycin, and Meropenem: A Therapeutic Drug Monitoring Approach. Antibiotics (Basel, Switzerland) 13 (7) (2024)
Manuel Mena, Julio-Cesar García, Rosa Helena Bustos-Cruz
Implementing Vancomycin Population Pharmacokinetic Models: An App for Individualized Antibiotic Therapy in Critically Ill Patients. Antibiotics (Basel, Switzerland) 12 (2) (2023)
Ximena Bonilla, Ana Milena Lara, Manuela Llano-León, David A López-González, David Guillermo Hernández, Rosa Helena Bustos-Cruz, Bernardo Camacho-Rodríguez, Ana-María Perdomo-Arciniegas
Mesenchymal Stromal Cells from Perinatal Tissues as an Alternative for Ex Vivo Expansion of Hematopoietic Progenitor and Stem Cells from Umbilical Cord Blood. International journal of molecular sciences 24 (21) (2023)
Manuel Mena, Julio-Cesar García, Rosa Helena Bustos-Cruz
Implementing Vancomycin Population Pharmacokinetic Models: An App for Individualized Antibiotic Therapy in Critically Ill Patients. Antibiotics (Basel, Switzerland) 12 (2) (2023)
Manuel Mena, Julio-Cesar García, Rosa Helena Bustos-Cruz
Implementing Vancomycin Population Pharmacokinetic Models: An App for Individualized Antibiotic Therapy in Critically Ill Patients. Antibiotics (Basel, Switzerland) 12 (2) (2023)
Jose-Manuel Quintero, German Pulido, Luis-Fernando Giraldo, Marta-Ximena Leon, Luis-Eduardo Diaz, Rosa Helena Bustos-Cruz
A Systematic Review on Cannabinoids for Neuropathic Pain Administered by Routes Other than Oral or Inhalation. Plants (Basel, Switzerland) 11 (10) (2022)
Milton Arias, Henry Oliveros, Sharon Lechtig-Wasserman, Rosa Helena Bustos-Cruz
Biologics in COVID-19 So Far: Systematic Review. Pharmaceuticals (Basel, Switzerland) 15 (7) (2022)
Sara Arias, Marta Leon, Diego Alejandro Jaimes, Rosa Helena Bustos-Cruz
Clinical Evidence of Magistral Preparations Based on Medicinal Cannabis. Pharmaceuticals (Basel, Switzerland) 14 (2) (2021)
Jose Sanabria, Vivian Garzón, Tatiana Pacheco, Maria-Paula Avila, Julio-Cesar García, Diego Alejandro Jaimes, Angela Torres, Rosa Helena Bustos-Cruz, Javier Escobar-Pérez, Deisy Abril
Estimation of the Difference in Colistin Plasma Levels in Critically Ill Patients with Favorable or Unfavorable Clinical Outcomes. Pharmaceutics 13 (10) (2021)
Sharon Lechtig-Wasserman, Hans Liebisch-Rey, Nicolas Diaz-Pinilla, Jhosep Blanco, Yuli-Viviana Fuentes-Barreiro, Rosa Helena Bustos-Cruz
Carbapenem Therapeutic Drug Monitoring in Critically Ill Adult Patients and Clinical Outcomes: A Systematic Review with Meta-Analysis. Antibiotics (Basel, Switzerland) 10 (2) (2021)
Carolina Osorio, Laura Garzón, Diego Alejandro Jaimes, Edwin Silva, Rosa Helena Bustos-Cruz
Impact on Antibiotic Resistance, Therapeutic Success, and Control of Side Effects in Therapeutic Drug Monitoring (TDM) of Daptomycin: A Scoping Review. Antibiotics (Basel, Switzerland) 10 (3) (2021)
Vivian Garzón, Rosa Helena Bustos-Cruz, Daniel G Pinacho
Personalized Medicine for Antibiotics: The Role of Nanobiosensors in Therapeutic Drug Monitoring. Journal of personalized medicine 10 (4) (2020)
Sandra Rodríguez, Andrés Muñoz, Rosa Helena Bustos-Cruz, Diego Alejandro Jaimes
Pharmacovigilance of Biopharmaceuticals in Rheumatic Diseases, Adverse Events, Evolution, and Perspective: An Overview. Biomedicines 8 (9) (2020)
Maria-Paula Avila, Tatiana Pacheco, Sara Arias, Rosa Helena Bustos-Cruz, Julio-Cesar García, Diego Alejandro Jaimes
Is There a Role for the Therapeutic Drug Monitoring of Colistin? An Overview. Pharmaceuticals (Basel, Switzerland) 13 (3) (2020)
Tatiana Pacheco, Rosa Helena Bustos-Cruz, Deisy Abril, Sara Arias, Lina Uribe, Jenny Rincón, Julio-Cesar García, Javier Escobar-Pérez
Pseudomonas aeruginosa Coharboring BlaKPC-2 and BlaVIM-2 Carbapenemase Genes. Antibiotics (Basel, Switzerland) 8 (3) (2019)
Tatiana Pacheco, Rosa Helena Bustos-Cruz, Diana González, Vivian Garzón, Julio-Cesar García, Daniela Ramírez
An Approach to Measuring Colistin Plasma Levels Regarding the Treatment of Multidrug-Resistant Bacterial Infection. Antibiotics (Basel, Switzerland) 8 (3) (2019)
Vivian Garzón, Daniel G Pinacho, Rosa Helena Bustos-Cruz, Gustavo Garzón, Sandra Bustamante
Optical Biosensors for Therapeutic Drug Monitoring. Biosensors 9 (4) (2019)
Julio-Cesar García, Rosa Helena Bustos-Cruz
The Genetic Diagnosis of Neurodegenerative Diseases and Therapeutic Perspectives. Brain sciences 8 (12) (2018)
Rosa Helena Bustos-Cruz, Carlos Zapata, Efraín Esteban, Julio-Cesar García, Edwin Jáuregui, Diego Jaimes
Label-Free Quantification of Anti-TNF-α in Patients Treated with Adalimumab Using an Optical Biosensor. Sensors (Basel, Switzerland) 18 (3) (2018)
Rosa Helena Bustos-Cruz, Luis Rafael Martínez, Julio-Cesar García, George E Barreto, Fernando Suárez-Obando
New ABCC2 rs3740066 and rs2273697 Polymorphisms Identified in a Healthy Colombian Cohort. Pharmaceutics 10 (3) (2018)